Soon K. Low

Online Research Club
Kuala Selangor, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond.

Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond.

Journal: Journal of immunotherapy and precision oncology

Published: November 14, 2025

Clinical Outcomes and Prognostic Factors in Epithelial-Myoepithelial Carcinoma (EMC) of the Breast.

Clinical Outcomes and Prognostic Factors in Epithelial-Myoepithelial Carcinoma (EMC) of the Breast.

Journal: Clinical breast cancer

Published: August 21, 2024

Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020.

Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 08, 2024

Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia.

Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia.

Journal: American journal of hematology

Published: August 26, 2023

Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies.

Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies.

Journal: Journal of hematology

Published: October 01, 2022

Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study.

Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study.

Journal: Leukemia & lymphoma

Published: September 19, 2022

Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.

Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.

Journal: Thrombosis research

Published: June 21, 2022

Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.

Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.

Journal: Leukemia & lymphoma

Published: June 14, 2022

Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015.

Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015.

Journal: American journal of clinical oncology

Published: June 14, 2022

Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.

Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.

Journal: Oral oncology

Published: May 11, 2022

AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax.

AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax.

Journal: Leukemia research reports

Published: April 15, 2022

Severe Haemolytic Anaemia Resulting from a Malpositioned Haemodialysis Catheter.

Severe Haemolytic Anaemia Resulting from a Malpositioned Haemodialysis Catheter.

Journal: European journal of case reports in internal medicine

Published: July 23, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026